Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.46    -0.14 (-3.04%)
Bid:
4.41
Ask:
4.545
Spread: 0.135 (3.061%)
Market Cap: £214.06m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Major Industry Awards Win

10 Apr 2006 09:19

Seeing Machines Limited10 April 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") Monday 10 April 2006 Seeing Machines Wins Major Industry Awards for Glaucoma Project Seeing Machines (AIM:SEE) was awarded two iAwards at the AIIA's galapresentation dinner last Friday night (7 April) for its glaucoma diagnosticdevice development. • The "Local Industry Award" - for the most innovative ICT project undertaken by an Australian local industry company (small-to-medium enterprise), and • The "Research and Development Award" - for the most outstanding ICT R& D project The iAwards, Australia's premier industry awards for the Information andCommunications Technology (ICT) sector, are awarded by the AustralianInformation Industry Association (AIIA) for outstanding ICT solutions across 15categories from Agriculture & Primary Industries, e-Government & Service,Research & Development through to Tourism & Hospitality. In addition there arefive major awards: the Local Industry Award, Community Award, InnovativeCommercial Software Award, the Inspiration Award and the CSIRO Tony BensonAward. Seeing Machines won the iAward for the Research and Development category, andthen also picked up the major Local Industry Award for the most innovative ICTproject undertaken by an Australian SME. Seeing Machines is developing the world's first non-contact objective device fordiagnosing glaucoma and a range of other eye diseases, utilising itsmarket-leading, patent-protected computer vision technology. These nationalawards recognize the progress that has been made to date in this project and thesignificant commercial opportunity arising from the pioneering work of theSeeing Machines team and its colleagues at the Research School of BiologicalSciences at the Australian National University. Seeing Machines would like tothank the AIIA for its recognition of this important work. The full list of iAwards is available at: www.aiia.com.au/i-cms.isp?page=1290. -- ends -- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com About the AIIA and the iAwards Details about the Australian Information Industry Association (AIIA) areavailable here: www.aiia.com.au/i-cms.isp?page=13 Details about the iAwards are available here: www.aiia.com.au/i-cms.isp?page=243. About Seeing Machines Seeing Machines is an award winning Technology Company which focuses on visionbased human machine interfaces. Formed in 2000 in Canberra, Australia, SeeingMachines' purpose is to commercialise its computer-vision across a range ofindustries and applications. Seeing Machines deliver advanced computer vision solutions for researches anddeveloper in human factors, transportation safety, computer human interaction,robotics, medical research and psychology. The flagship product faceLABTMprovides an automated and contact-free gaze and head tracking technology, itsolves the problem of observing human behaviour naturally, non-intrusively andwith a high degree of accuracy and usability. faceLABTM is a computer vision system that is able to measure the orientationand position of a human head, as well as detect blinks and estimategaze-direction. It achieves all of this completely visually through a stereocamera system connected to advanced image processing software, with noattachments required on the subject. The product is designed to allow humanfactors researchers and designers assess the interaction of an operator in anenvironment and this finds application in designing operator environments, suchas cockpits for cars, trucks, trains, and aeroplanes for instance, and otherindustrial design applications, as well as medical and psychological researchsituations. The technology also has application in monitoring automobiledrivers and if it detects drowsiness or that the driver is distracted and theirattention has been diverted from the road, an alarm can be raised to alert thedriver to either pull over and rest in the case of drowsiness or to pay moreattention to the road. faceLABTM works in real-time, enabling the behaviour of a subject to be tracked.This technology is paving the way in promoting safer driving conditions andworks to enhance the driving experience and to eliminate accidents causedthrough driver drowsiness or distraction. There are many different sectors that can benefit from this revolutionarysoftware, for which it has been developed, including: automotive; academicresearch; medicine/healthcare; defence; autostereoscopy (next generationdisplays); sport; and games. Seeing Machines is currently working with researchers from the Research Schoolof Biological Sciences at the Australian National University to enable a newobjective method for diagnosing and managing glaucoma, a leading source ofblindness. This technology could complement or replace existing visual fieldtesting devices used by more than 70,000 ophthalmologists globally and may haveapplication in detecting other eye and neurological diseases. Seeing Machinesis developing a technology based on a completely objective method that uses aninvoluntary physiological response. This has the potential to become a 'goldstandard' in the diagnosis and management of glaucoma to derive reliable,repeatable results and greater diagnostic accuracy. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jun 20217:00 amRNSSEE and CAE to deliver Crew Training System
7th Jun 20217:00 amRNS21st Century Smart Cars Act Legislation
28th Apr 20217:09 amRNSDMS central to improved safety on US roads
26th Apr 20217:00 amRNSDMS award brings OEM customer count to seven
31st Mar 20217:00 amRNSHalf-year results and financial report
22nd Mar 20217:00 amRNSIssue of shares and total voting rights
19th Mar 20217:16 amRNSNotice of Results and Investor Presentation
8th Feb 20217:00 amRNSSEE DMS Available in 2021 Cadillac Escalade
3rd Feb 20217:30 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSHalf year trading update
27th Jan 20217:00 amRNSQualcomm and Seeing Machines collaboration
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20218:48 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSLicense Agreement with OmniVision Technologies
22nd Dec 20207:00 amRNSFleet Update
30th Nov 20209:19 amRNS2020 AGM Results and Board Changes
25th Nov 202011:50 amRNSDirector/PDMR Shareholding
23rd Nov 202010:00 amRNSShare Transfer & Issue of Performance Rights
5th Nov 20208:02 amRNSNotice of AGM
2nd Nov 202011:43 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSYear End Results
30th Oct 20209:19 amRNSHolding(s) in Company
30th Oct 20207:00 amRNSWebcast Presentation - Year End Results
29th Oct 202011:39 amRNSHolding(s) in Company
29th Oct 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSIssue of Shares & Total Voting Rights
21st Oct 20207:00 amRNSSEE signs MOU with L3Harris Technologies
12th Oct 20207:00 amRNSSEE extends leading DMS to Occupant Monitoring
16th Sep 20207:15 amRNS5 billion kilometres of Guardian driving data
14th Sep 20207:00 amRNSLaunch of DMS Kit on Qualcomm Snapdragon Platform
8th Sep 20209:05 amRNSSecond Price Monitoring Extn
8th Sep 20209:00 amRNSPrice Monitoring Extension
8th Sep 20207:00 amRNSSEE signs MOU with leading Semiconductor Company
2nd Sep 20209:00 amRNSNext Gen Embedded Product Strategy for Auto DMS
14th Aug 202010:55 amRNSShare purchase by PCA of non-executive director
3rd Aug 20207:00 amRNSFY20 Trading Update
7th Jul 20207:00 amRNSUS set to mandate DMS from 2024
19th May 20207:00 amRNSBusiness restructure and Covid measures
14th May 20207:00 amRNSBoard Changes
6th May 202011:05 amRNSSecond Price Monitoring Extn
6th May 202011:00 amRNSPrice Monitoring Extension
5th May 20204:41 pmRNSSecond Price Monitoring Extn
5th May 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20201:53 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSDirector/PDMR Shareholding
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:35 pmRNSPrice Monitoring Extension
2nd Apr 20202:06 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.